(1) Protective effects of different CD14+CD16+ monocyte subsets and their frequency and phenotypic changes in treated, vaccinated and other TB patients. (2) Functional role of haemocyte subpopulations and the presence and role of DC subpopulations in CD14+CD16+ monocytes. This evidence concerns the gene CD14 and tuberculosis.